Cameron Searle, PA
Physician Assistant · Rochester, MNNPI 1851025183
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,558 of the $5,828 with a category attached, or 78.2%. 27 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 24.8% of the total. Reporting peaked in 2023 at $2,937 and has fallen 99.4% since, to $17 in 2025. Among physician assistant clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 225 payments — averaging $25.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$1K
- AstraZeneca$992
- GSK$517
- Mylan Specialty L.p.$334
- Takeda Pharmaceuticals U.S.A., Inc.$301
- Harmony Biosciences LLC$297
- plus $2K from 21 others
What the payments were for
- Travel & lodging$1,07919%
- Food & beverage$4,55878%
- Education$1913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 22 | $1,445 |
| AstraZeneca | 41 | $992 |
| GSK | 31 | $517 |
| Mylan Specialty L.p. | 20 | $334 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $301 |
| Harmony Biosciences LLC | 12 | $297 |
| Axsome Therapeutics, Inc. | 15 | $274 |
| Regeneron Healthcare Solutions, Inc. | 5 | $258 |
| Grifols USA, LLC | 9 | $204 |
| Sanofi | 8 | $180 |
| United Therapeutics Corporation | 8 | $151 |
| Philips North America LLC | 9 | $132 |
| Merck | 5 | $103 |
| Actelion Pharmaceuticals US, Inc. | 3 | $83 |
| Vifor Pharma, Inc. | 3 | $83 |
| Bayer | 4 | $81 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $74 |
| Boehringer Ingelheim | 3 | $72 |
| Amgen | 3 | $57 |
| Jazz Pharmaceuticals Inc. | 1 | $34 |
| Resmed Corp | 2 | $32 |
| Hologic Sales And Service, LLC | 1 | $29 |
| Optinose US, Inc. | 1 | $27 |
| Sandoz | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Itamar Medical Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,828 in reported general payments places this provider in the 95th percentile of 3,121 physician assistant providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 18 | $231,598 |
| OpsumitMacitentan | 14 | $179,678 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 195 | $133,992 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 151 | $117,684 |
| Fasenra PenBenralizumab | 11 | $66,032 |
| Spiriva RespimatTiotropium Bromide | 77 | $55,158 |
| SymbicortBudesonide/Formoterol Fumarate | 127 | $42,083 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 67 | $34,208 |
| Advair HfaFluticasone Propion/Salmeterol | 53 | $24,769 |
| Breo ElliptaFluticasone/Vilanterol | 32 | $15,070 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 63 | $14,282 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 55 | $8,538 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $7,250 |
| BreynaBudesonide/Formoterol Fumarate | 34 | $6,202 |
| AirsupraAlbuterol Sulfate/Budesonide | 13 | $5,954 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat | $72 | $320,963162 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Airsupra | $992 | $182,029335 claims |
| Actelion Pharmaceuticals US, Inc.Opsumit | $83 | $179,67814 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta | $517 | $142,641208 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,121 physician assistant providers in Minnesota.
Other physician assistant in Rochester
- Sarah SchettleRochester$150K
- Chelsey HoffmannRochester$19K
- Amber KoehlerRochester$13K
- Sarah StuartRochester$6K
- Carroll PoppenRochester$5K
- Elise TentisRochester$5K
- Kelly ObergRochester$4K
- Sara RobeckBloomington$274K
- Natalie IkemanEdina$170K
- Adam HetzBlaine$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.